(-)-Syringaresinol-4-O-β-D-glucopyranoside

(4aS,16aS)-3,4,4a,5,16a,17,18,19-Octahydro-12,20,21,22,26-pentamethoxy-4,17-dimethyl-16H-1,24:6,9-dietheno-11,15-metheno-2H-pyrido[2′,3′:17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline (ACI)

Immunoglobulin G1, anti-(human epidermal growth factor receptor extracellular domain III) (human-Mus musculus monoclonal 992 DS heavy chain), disulfide with human-Mus musculus monoclonal 992 DS light chain, dimer (ACI)

Magnolin

Immunoglobulin G1, anti-(human blood-coagulation factor III) (human monoclonal HuMax-TF heavy chain), disulfide with human monoclonal HuMax-TF κ-chain, dimer (ACI)

Immunoglobulin G2a, anti-(human neuregulin receptor HER3) (human monoclonal MM-121 heavy chain), disulfide with human monoclonal MM-121 λ-chain, dimer (ACI)

Carotuximab

Anifrolumab

Ozanezumab

Abciximab

Immunoglobulin G1, anti-(Clostridium difficile toxin B) (human monoclonal γ-chain), disulfide with human monoclonal κ-chain, dimer (ACI)

Evolocumab

Carboxyfluorescein succinimidyl ester

Tregalizumab

Narnatumab

Sirukumab

2H-Indol-2-one, 1,3-dihydro-5-methoxy-3-[[3-[(1E)-2-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]ethenyl]-1H-indazol-6-yl]methylene]-, hydrochloride (1:2) (ACI)

Atinumab

DNA, d(P-thio)(T-C-C-T-G-G-C-G-G-G-G-A-A-G-T) (ACI)

Crenezumab